Chemed Corporation provides hospice and palliative care services in the United States. It operates through two segments, VITAS and Roto-Rooter. The VITAS segment offers direct medical services, as well as spiritual and emotional counseling services to terminally ill patients. This segment offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and operated territories, independent contractor-operated territories, and franchised locations. This segment also manufactures and sells products and equipment, including drain cleaning machines and drain cleaning solutions. The company was founded in 1970 and is headquartered in Cincinnati, Ohio.
Industry, Sector and Symbol
Industry Home health care services
Sub-IndustryHealth Care Services
SectorMedical
Phone513-762-6690
Debt
Current Ratio1.14
Quick Ratio1.11
Price-To-Earnings
Sales & Book Value
Annual Sales$1.67 billion
Price / Sales2.76
Price / Cash Flow35.67
Price / Book8.51
Profitability
Net Income$98.17 million
Net Margins11.73%
Return on Assets20.40%
Miscellaneous
Employees14,813
OptionableOptionable
Chemed (NYSE:CHE) Frequently Asked Questions
What is Chemed's stock symbol?
Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."
How often does Chemed pay dividends? What is the dividend yield for Chemed?
Chemed announced a quarterly dividend on Friday, November 2nd. Investors of record on Monday, November 12th will be paid a dividend of $0.30 per share on Monday, December 3rd. This represents a $1.20 dividend on an annualized basis and a yield of 0.42%. The ex-dividend date of this dividend is Thursday, November 8th. View Chemed's Dividend History.
How will Chemed's stock buyback program work?
Chemed declared that its Board of Directors has authorized a stock buyback plan on Wednesday, March 7th 2018, which allows the company to buyback $150,000,000.00 in shares, according to EventVestor. This buyback authorization allows the company to purchase shares of its stock through open market purchases. Shares buyback plans are typically an indication that the company's leadership believes its shares are undervalued.
How were Chemed's earnings last quarter?
Chemed Co. (NYSE:CHE) announced its quarterly earnings results on Monday, October, 29th. The company reported $3.07 EPS for the quarter, topping the Zacks' consensus estimate of $2.80 by $0.27. The business earned $444.15 million during the quarter, compared to the consensus estimate of $445.16 million. Chemed had a return on equity of 35.13% and a net margin of 11.73%. Chemed's revenue was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.15 EPS. View Chemed's Earnings History.
When is Chemed's next earnings date?
What guidance has Chemed issued on next quarter's earnings?
Chemed issued an update on its FY18 earnings guidance on Monday, October, 29th. The company provided earnings per share (EPS) guidance of $11.80-11.90 for the period, compared to the Thomson Reuters consensus EPS estimate of $11.47. Chemed also updated its FY 2018 guidance to $11.80-11.90 EPS.
What price target have analysts set for CHE?
3 equities research analysts have issued twelve-month price targets for Chemed's shares. Their predictions range from $275.00 to $390.00. On average, they expect Chemed's stock price to reach $328.6667 in the next twelve months. This suggests a possible upside of 14.2% from the stock's current price. View Analyst Price Targets for Chemed.
What is the consensus analysts' recommendation for Chemed?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Chemed.
Has Chemed been receiving favorable news coverage?
Media headlines about CHE stock have trended positive this week, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Chemed earned a media sentiment score of 2.6 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 8.0 out of 10, indicating that recent press coverage is very likely to have an effect on the stock's share price in the next few days.
Who are some of Chemed's key competitors?
Who are Chemed's key executives?
Chemed's management team includes the folowing people:
- Mr. Kevin J. McNamara, CEO, Pres & Director (Age 64)
- Mr. David P. Williams, Exec. VP & CFO (Age 57)
- Ms. Naomi C. Dallob, VP, Chief Legal Officer & Sec. (Age 64)
- Mr. Spencer S. Lee, Exec. VP (Age 62)
- Mr. Nicholas Michael Westfall, Exec. VP (Age 39)
Who are Chemed's major shareholders?
Chemed's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Riverbridge Partners LLC (2.93%), Boston Advisors LLC (0.13%), Cape Cod Five Cents Savings Bank (0.03%), TrimTabs Asset Management LLC (0.03%), Louisiana State Employees Retirement System (0.03%) and State of Alaska Department of Revenue (0.02%). Company insiders that own Chemed stock include Arthur V Tucker Jr, David Patrick Williams, Donald E Saunders, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace and Spencer S Lee. View Institutional Ownership Trends for Chemed.
Which institutional investors are selling Chemed stock?
CHE stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Denali Advisors LLC, Meeder Asset Management Inc., Oakbrook Investments LLC, Louisiana State Employees Retirement System, State of Alaska Department of Revenue and Delta Capital Management LLC. Company insiders that have sold Chemed company stock in the last year include David Patrick Williams, Donald E Saunders, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace and Spencer S Lee. View Insider Buying and Selling for Chemed.
Which institutional investors are buying Chemed stock?
CHE stock was purchased by a variety of institutional investors in the last quarter, including TrimTabs Asset Management LLC, Highland Capital Management LLC, Boston Advisors LLC, Cape Cod Five Cents Savings Bank and First Hawaiian Bank. Company insiders that have bought Chemed stock in the last two years include Donald E Saunders and George J Walsh III. View Insider Buying and Selling for Chemed.
How do I buy shares of Chemed?
Shares of CHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Chemed's stock price today?
One share of CHE stock can currently be purchased for approximately $287.82.
How big of a company is Chemed?
Chemed has a market capitalization of $4.55 billion and generates $1.67 billion in revenue each year. The company earns $98.17 million in net income (profit) each year or $5.36 on an earnings per share basis. Chemed employs 14,813 workers across the globe.
What is Chemed's official website?
How can I contact Chemed?
Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The company can be reached via phone at 513-762-6690.
MarketBeat Community Rating for Chemed (NYSE CHE)
MarketBeat's community ratings are surveys of what our community members think about Chemed and other stocks. Vote "Outperform" if you believe CHE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CHE will underperform the S&P 500 over the long term. You may vote once every thirty days.
